Biological Model and Pharmacotherapy in Internet Addiction
Article information
J Korean Med Assoc. 2006;49(3):209-214
Publication date (electronic) : 2006 March 31
doi :
https://doi.org/10.5124/jkma.2006.49.3.209
Abstract
Internet addiction, a kind of behavioral addiction, has recently emerged as a big social issue among Korean adolescents. However, medical researches on the internet addiction has just started. Through a review of the literature on drug addiction and pathologic gambling, which are thought to be similar to the internet addiction, the author summarized biological aspects of internet addiction and currently available medications for the addicts.
Keywords: Internet Addiciton; Biological etiology; Medications
References
1. Goldberg I. electronic message posted to research discussion list. Internet addiction 1996. [available online at http://avocado.pc.helsinki.fi/~janne/ikg/].
2. Young KS. Internet addiction : The emergence of a new clinical disorder 1996. In : Paper presented at the 104th annual meeting of the American Psychological Association. Toronto, Canada.
3. Cloninger CR, Dragan M, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993. 50975–990.
4. Cloninger CR. In : Silk KR, ed. The genetics and psychobiology of the seven-factor model of personality. Biology of Personality Disorders 1998. Washington DC: American Psychiatry Press; 63–92.
7. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000. 126325–341.
8. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor variants: association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics 1995. 5121–141.
9. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S. A genetic association for cigarrette smoking behavior. Health Psychol 1999. 187–13.
10. Muramatsu T, Higuchi S, Murayama M, Matsushita S, Hayashida M. Associstion between alcoholism and the dopamine D4 receptor gene. J Med Genet 1996. 33113–115.
11. Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Arinami T, et al. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev 1999. 8831–833.
12. Ashwin AP, Wade HB, Margret H, Charles CT, Edward G, Kevin H, et al. Serotonin transporter polymorphism and measures of impulsivity, aggression, and sensation-seeking among African-American cocaine-dependent individuals. Psychiatry Research 2002. 110103–115.
13. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhi GR, Lachman HM. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abuses. Am J Med Genet 1997. 74439–442.
14. Jerzy S, Jolanta KM, Ryszard K, Michael S, Hans R, Catrin W, et al. Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res 2002. 111229–233.
15. DeCaria CM, Begaz T, Hollander E. Serotonergic and noradrenergic function in pathological gambling. CNS Spectr 1998. 338–47.
16. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001. 49914–921.
17. Hollander E, Begaz T, DeCaria CM. Pharmacological approaches in the treatment of pathological gambling. CNS Spectr 1998. 972–80.
18. Carrion VG. Naltrexone for the treatment of trichotillomania: a case report. J Clin Psychopharmacol 1995. 15444–445.
Article information Continued
Copyright © 2006 Korean Medical Association
